Aspirin Suppository shortage
Aspirin Suppository is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Sep 22, 2026.
Padagis is permanently stopping production of aspirin suppositories (300 mg). No other manufacturer is currently listed as a source for this product.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Aspirin Suppository. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Jul 23, 2026Currently in shortage1 of 1 product affected.
-
Jul 23, 2026First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Padagis US LLC 📞 (800) 775-2054 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Aspirin, Suppository, 300 mg (NDC 0574-7034-12) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Aspirin Suppository — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Aspirin Suppository? options further down this page.
Why is Aspirin Suppository in shortage?
Padagis US LLC has reported to the FDA that they are permanently stopping the manufacture of their 300 mg aspirin suppositories (the 12-count package). That's the reason this product appears on the shortage list — it's not a temporary delay or a supply hiccup, but a full discontinuation of that specific product by this manufacturer.
It's worth knowing that Padagis did not share a more detailed reason for why they made this decision — just that they are stopping production of it. No specific reason was provided in the FDA report beyond the discontinuation itself.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Aspirin Suppository, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Aspirin Suppository?
Aspirin suppositories, 300 mg, are currently listed on the FDA drug-shortage report. I want to walk you through what this means so you can plan your next steps calmly.
The only strength on this record is the 300 mg suppository, and it does not have an available source right now. The manufacturer that filed this report, Padagis US LLC, lists the reason as a discontinuation of the manufacture of the drug. Because this is marked "to be discontinued," this supply problem may be permanent rather than temporary. No other maker is listed on this record, so I don't have a same-medicine option to point you to here.
Please keep in mind this information comes from national, manufacturer-reported data and may not match what any single pharmacy has on its shelves.
Here is what I suggest, in order:
- Do not stop, skip, or change how you use this medicine on your own.
- Because this strength is being discontinued, ask your prescriber or pharmacist about options — for example a clinician-chosen alternative that fits your needs.
- Your pharmacy can also check wholesalers and other manufacturers to see whether any supply remains.
- The manufacturer's contact number is listed on this page for reference; pharmacies usually handle those calls.
A short conversation with your prescriber is the right next step.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Aspirin Suppository?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Aspirin Suppository is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Alternative dosage forms of Aspirin
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 1 productclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| aspirin 300 mg | Padagis | 12 suppositories | — | — | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Aspirin Suppository — that fall in the same broad treatment class (analgesic/antipyretics, salicylates) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Aspirin Suppository shortage FAQs
Is Aspirin Suppository in shortage?
Which products are affected?
When will Aspirin Suppository be available again?
Can I still get Aspirin somewhere?
What should I do if I take Aspirin Suppository?
Still have a question about the Aspirin Suppository shortage?
Ask a pharmacist about this shortage →View Aspirin Suppository on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.